Risk Appetite Returns To Biotech With IBB Up Over 3%

source link http://newemangelization.com/uncategorized/priests-need-to-lead-catholic-men-through-basic-training/ Rayno Life Science Stocks -Green Screen Rules-NASDAQ (4168) Up 1.16%

  • Speculative ETF XBI (134.50) up 4.69% and 7.88% over 5 days; 52 week high $172.52.
  • ETF PBE ($40.85)  up over 3%.
  • Momentum stocks are soaring but way off all time highs in February.
  • Big Rayno Biopharma Movers: ACHN up 8%, ALKS up 3.4%, ARIA up 5.3%, CBST up 4.5%. IMGN up 4.34%, PCYC up 5.9%, SGEN up 5.3%…etc.
  • Big Rayno Dx and Tools Movers: EXAS up 3.76%, GHDX up 4.8%, ILMN up 4.6%, SQNM up 4.9% ..etc.
  • Healthcare ETF XLV  ($58.40) now up 5.4% YTD.
  • Valeant Bid for Allergan is a Catalyst for sector.

Amgen (AMGN) , Cubist (CBST), Gilead (GILD), and Illumina (ILMN) earnings after the close. All are on our focus list.

Asset trade with Glaxo (GSK) , Lilly(LLY) and Novartis (NVS) reshapes product direction.

Our index of 55 mid-cap biopharma stocks is up a huge 10.2% driven by AGIO, ICPT, NKTR and SRPT. Shorts are covering and institutions have plenty of fire-power. There is only ONE stock down so if you have a loser today sell it. http://agahitehran.com/?search=انواع سوئيچ مدل IRS-10N-GF Speculation returns.

All that matters near term are earnings from large caps and technicals. All Rayno Life Science stocks are holds. The bull is back.

Chart foriShares Nasdaq Biotechnology (IBB)

, , , ,

No comments yet.

Leave a Reply